Skip to content
OpenCapital
Get started

Ibotta IBTA Capitalized research and development

Capitalized research and development at other companies

BillionToOne, Inc. logo
BillionToOne, Inc. BLLN
$6.06M-47.2%
ESAB logo
ESABESAB
$22.04M+7.2%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$39.94M-11.2%
Kadant logo
KadantKAI
$3.85M-17.8%
Parker-Hannifin logo
Parker-HannifinPH
$172M+17.8%
Hubbell logo
HubbellHUBB
$32.5M-42.2%

Other financials

Income statement

See full
Revenue$82.5M-2.5%
Gross profit$63.0M-6.6%
Operating income-$10.8M-286%
Net income-$10.3M-1,960%
EPS (diluted)-$0.43-2,250%

Balance sheet

See full
Cash & equivalents$164.6M-44.7%
Total debt$25.3M-1.1%
Total equity$249.0M-38.0%
Total assets$479.9M-24.9%

Cash flow

See full
Operating cash flow$30.4M+52.9%
CapEx$3.1M+62.0%
Free cash flow$27.3M+52.0%

Valuation

See full
Market cap$744.33M-23.5%
Enterprise value$605.06M-13.6%
P/S2.2×-0.4×

Profitability

See full
Gross margin78.4%-6.2pp
Operating margin-2.6%-5.1pp
Net margin22.9%+19.9pp
FCF margin24.8%-6.0pp

Returns & leverage

See full
Return on equity22.8%+16.9pp
Debt / equity0.1×0.0×
Current ratio1.8×-0.9×

Where this comes from

Reported directly by Ibotta in its filing.

Tagged under the XBRL concept ibta:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts.

The official record: Ibotta’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ibotta's capitalized research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ibotta's capitalized research and development?
Ibotta (IBTA) reported capitalized research and development of $22.65M in Q4 2025.
What is the long-term trend for Ibotta's capitalized research and development?
Over 2 years (2023 to 2025), Ibotta's capitalized research and development has grown at a -13.5% compound annual growth rate (CAGR), from $30.29M to $22.65M.
What does capitalized research and development mean?
This represents the portion of research and development expenditures that have been capitalized as an asset rather than expensed immediately in the period incurred. Capitalization occurs when costs meet specific criteria for future economic benefit, such as software development for internal use or platform enhancements. This metric provides insight into the company's investment in long-term innovation and technology infrastructure.